Pathways’ Picks November 21: FDA Nominee Faces Questions, and More

article image

Stephen Hahn faced questions from senators weighing his nomination to be FDA’s next commissioner, and more US regulatory updates in the November 21 edition of Pathways’ Picks, MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news.

Medical devices got precious little attention during the November 20 Senate hearing to vet Stephen Hahn, who seems to have a clear path to be confirmed as the next FDA commissioner. Hahn’s confirmation hearing leads this week’s Pathways’ Picks—a rundown of medtech policy happenings and key dates that should be on your radar. 

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: